Traumatic Injury to the Immature Brain: Inflammation, Oxidative Injury, and Iron-Mediated Damage as Potential Therapeutic Targets

被引：15

作者：

Potts M.B. ^{[1
]}

Koh S.-E. ^{[1
]}

Whetstone W.D. ^{[2
]}

Walker B.A. ^{[2
]}

Yoneyama T. ^{[1
]}

Claus C.P. ^{[1
]}

Manvelyan H.M. ^{[1
]}

Noble-Haeusslein L.J. ^{[1
]}

机构：

[1] Department of Neurological Surgery, University of California, San Francisco

[2] Department of Medicine (Division of Emergency Medicine), University of California, San Francisco

来源：

NeuroRX | 2006年 / 3卷 / 2期

基金：

美国国家卫生研究院;

关键词：

immature brain; inflammation; iron; oxidative damage; Traumatic brain injury;

D O I：

10.1016/j.nurx.2006.01.006

中图分类号：

学科分类号：

摘要：

Traumatic brain injury (TBI) is the leading cause of morbidity and mortality among children and both clinical and experimental data reveal that the immature brain is unique in its response and vulnerability to TBI compared to the adult brain. Current therapies for pediatric TBI focus on physiologic derangements and are based primarily on adult data. However, it is now evident that secondary biochemical perturbations play an important role in the pathobiology of pediatric TBI and may provide specific therapeutic targets for the treatment of the head-injured child. In this review, we discuss three specific components of the secondary pathogenesis of pediatric TBI - inflammation, oxidative injury, and iron-induced damage - and potential therapeutic strategies associated with each. The inflammatory response in the immature brain is more robust than in the adult and characterized by greater disruption of the blood-brain barrier and elaboration of cytokines. The immature brain also has a muted response to oxidative stress compared to the adult due to inadequate expression of certain antioxidant molecules. In addition, the developing brain is less able to detoxify free iron after TBI-induced hemorrhage and cell death. These processes thus provide potential therapeutic targets that may be tailored to pediatric TBI, including anti-inflammatory agents such as minocycline, antioxidants such as glutathione peroxidase, and the iron chelator deferoxamine. © 2006 The American Society for Experimental NeuroTherapeutics, Inc.

引用

页码：143 / 153

页数：10

共 148 条

[1]

Langlois J., Rutland-Brown W., Thomas K., Traumatic brain injury in the United States. Emergency department visits, hospitalizations, and deaths, (2004)

[2]

Mazzola C.A., Adelson P.D., Critical care management of head trauma in children, Crit Care Med, 30, (2002)

[3]

Costeff H., Groswasser Z., Goldstein R., Long-term follow-up review of 31 children with severe closed head trauma, J Neurosurg, 73, pp. 684-687, (1990)

[4]

Salmond C.H., Sahakian B.J., Cognitive outcome in traumatic brain injury survivors, Curr Opin Crit Care, 11, pp. 111-116, (2005)

[5]

Levin H.S., Aldrich E.F., Saydjari C., Eisenberg H.M., Foulkes M.A., Bellefleur M., Et al., Severe head injury in children. experience of the Traumatic Coma Data Bank, Neurosurgery, 31, pp. 435-443, (1992)

[6]

Khoshyomn S., Tranmer B.I., Diagnosis and management of pediatric closed head injury, Semin Pediatr Surg, 13, pp. 80-86, (2004)

[7]

Adelson P.D., Clyde B., Kochanek P.M., Wisniewski S.R., Marion D.W., Yonas H., Cerebrovascular response in infants and young children following severe traumatic brain injury. a preliminary report, Pediatr Neurosurg, 26, pp. 200-207, (1997)

[8]

Koskiniemi M., Kyykka T., Nybo T., Jarho L., Long-term outcome after severe brain injury in preschoolers is worse than expected, Arch Pediatr Adolesc Med, 149, pp. 249-254, (1995)

[9]

Bittigau P., Sifringer M., Felderhoff-Mueser U., Ikonomidou C., Apoptotic neurodegeneration in the context of traumatic injury to the developing brain, Exp Toxicol Pathol, 56, pp. 83-89, (2004)

[10]

Adelson P.D., Bratton S.L., Carney N.A., Chesnut R.M., du Coudray H.E., Goldstein B., Et al., Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents, Pediatr Crit Care Med, 4, (2003)

← 1 2 3 4 5 6 7 8 9 10 →